Table of Contents Author Guidelines Submit a Manuscript
Pathology Research International
Volume 2011, Article ID 860584, 6 pages
http://dx.doi.org/10.4061/2011/860584
Research Article

Disease Extent ≥4 cm Is a Prognostic Marker of Local Recurrence in T1-2 Breast Cancer

1Department of Pathology and Clinical Cytology, Central Hospital Falun, SE-791 82 Falun, Sweden
2Center for Clinical Research Dalarna, Uppsala University, Nissers väg 3, 791 82 Falun, Sweden

Received 25 April 2011; Revised 8 June 2011; Accepted 13 June 2011

Academic Editor: Gary Tse

Copyright © 2011 D. Lindquist et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Fisher, S. Anderson, J. Bryant et al., “Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer,” New England Journal of Medicine, vol. 347, no. 16, pp. 1233–1241, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. U. Veronesi, N. Cascinelli, L. Mariani et al., “Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer,” New England Journal of Medicine, vol. 347, no. 16, pp. 1227–1232, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Mannino and J. R. Yarnold, “Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?” Radiotherapy and Oncology, vol. 90, no. 1, pp. 14–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Luini, J. Rososchansky, G. Gatti et al., “The surgical margin status after breast-conserving surgery: Discussion of an open issue,” Breast Cancer Research and Treatment, vol. 113, no. 2, pp. 397–402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Morrow, “Margins in breast-conserving therapy: Have we lost sight of the big picture?” Expert Review of Anticancer Therapy, vol. 8, no. 8, pp. 1193–1196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Sanghani, E. Balk, B. Cady, and D. Wazer, “Predicting the risk of local recurrence in patients with breast cancer: an approach to a new computer-based predictive tool,” American Journal of Clinical Oncology, vol. 30, no. 5, pp. 473–480, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. R. G. Faverly, J. H. C. L. Hendriks, and R. Holland, “Breast carcinomas of limited extent: Frequency, radiologic-pathologic characteristics, and surgical margin requirements,” Cancer, vol. 91, no. 4, pp. 647–659, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Tot, “The metastatic capacity of multifocal breast carcinomas: extensive tumors versus tumors of limited extent,” Human Pathology, vol. 40, no. 2, pp. 199–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. L. Egan, “Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival,” Cancer, vol. 49, no. 6, pp. 1123–1130, 1982. View at Google Scholar · View at Scopus
  11. R. Holland, S. H. J. Veling, M. Mravunac, and J. H. C. L. Hendriks, “Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast-conserving surgery,” Cancer, vol. 56, no. 5, pp. 979–990, 1985. View at Google Scholar · View at Scopus
  12. E. E. Deurloo, W. F. A. Klein Zeggelink, H. J. Teertstra et al., “Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients,” European Radiology, vol. 16, no. 3, pp. 692–701, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Pedersen, K. A. Gunnarsdottir, B. B. Rasmussen, S. Moeller, and C. Lanng, “The prognostic influence of multifocality in breast cancer patients,” Breast, vol. 13, no. 3, pp. 188–193, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. J. K. Litton, Y. Eralp, A. M. Gonzalez-Angulo et al., “Multifocal breast cancer in women < or =35 years old,” Cancer, vol. 110, no. 7, pp. 1445–1450, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Tot, “Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections,” Cancer, vol. 110, no. 11, pp. 2551–2560, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Tot, G. Pekár, S. Hofmeyer, T. Sollie, M. Gere, and M. Tarján, “The distribution of lesions in 1-14-mm invasive breast carcinomas and its relation to metastatic potential,” Virchows Archiv, vol. 455, no. 2, pp. 109–115, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Tabár, T. Tot, and P. Dean, Breast Cancer. The Art an Science of Early Detection with Mammography, Thieme, Stuttgart, Germany, 2005.
  18. T. Tot, L. Tabár, and P. Dean, Practical Breast Pathology, Thieme, Stuttgart, Germany, 2002.
  19. T. Tot, “Towards a renaissance of subgross breast morphology,” European Journal of Cancer, vol. 46, no. 11, pp. 1946–1948, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. L. E. Joergensen, K. A. Gunnarsdottir, C. Lanng, S. Moeller, and B. B. Rasmussen, “Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996–2001,” Breast, vol. 17, no. 6, pp. 587–591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Vlastos, I. T. Rubio, N. Q. Mirza et al., “Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer,” Annals of Surgical Oncology, vol. 7, no. 8, pp. 581–587, 2000. View at Google Scholar · View at Scopus
  22. T. Tot, “Cost-benefit analysis of using large-format histology sections in routine diagnostic breast care,” Breast, vol. 19, no. 4, pp. 284–288, 2010. View at Publisher · View at Google Scholar · View at Scopus